Aquestive Therapeutics, Inc. Common Stock (AQST) is a publicly traded Healthcare sector company. As of July 17, 2026, AQST trades at $4.08 with a market cap of $494.34M and a P/E ratio of -6.56. AQST moved +4.70% today. Year to date, AQST is -36.22%; over the trailing twelve months it is -5.72%. Its 52-week range spans $2.12 to $7.55. Analyst consensus is strong buy with an average price target of $8.57. Rallies surfaces AQST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for AQST combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $4.08 |
| Market Cap | $494.34M |
| P/E Ratio | -6.56 |
| EPS | $-0.62 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.55 |
| 52-Week Low | $2.12 |
| Volume | 2.22M |
| Avg Volume | 0 |
| Revenue (TTM) | $50.27M |
| Net Income | $-68.91M |
| Gross Margin | 63.45% |
7 analysts cover AQST: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.57.